Sterling Powergensys Limited (BOM:513575)
India · Delayed Price · Currency is INR 35.29
-1.20 (-3.29%)
At close: Aug 5, 2025
Longboard Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 126.04 | 68.85 | 3.3 | 3.11 | 3.69 | Upgrade |
Other Revenue | - | - | - | 0 | - | Upgrade |
Revenue | 126.04 | 68.85 | 3.3 | 3.11 | 3.69 | Upgrade |
Revenue Growth (YoY) | 83.07% | 1986.31% | 6.07% | -15.61% | -96.70% | Upgrade |
Cost of Revenue | 121.74 | 64.53 | 0.25 | 3.03 | 2.41 | Upgrade |
Gross Profit | 4.3 | 4.31 | 3.05 | 0.08 | 1.27 | Upgrade |
Selling, General & Admin | 4.21 | 2.13 | 2.15 | 2.56 | 3.01 | Upgrade |
Other Operating Expenses | 9.32 | 7.34 | 3.66 | 2.94 | 1.17 | Upgrade |
Operating Expenses | 14.19 | 11.81 | 8.26 | 8.06 | 6.78 | Upgrade |
Operating Income | -9.89 | -7.5 | -5.21 | -7.98 | -5.51 | Upgrade |
Interest Expense | -1.19 | -1.39 | -1.88 | -1.19 | -2.27 | Upgrade |
Interest & Investment Income | - | 0.02 | 0.02 | 0.06 | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | 12.96 | -0.03 | -0.01 | -0.14 | -0.25 | Upgrade |
EBT Excluding Unusual Items | 1.89 | -8.9 | -7.08 | -9.25 | -8.02 | Upgrade |
Gain (Loss) on Sale of Assets | - | 37.25 | - | 10.28 | - | Upgrade |
Other Unusual Items | - | - | - | - | -3 | Upgrade |
Pretax Income | 1.89 | 28.35 | -7.08 | 1.03 | -11.02 | Upgrade |
Net Income | 1.89 | 28.35 | -7.08 | 1.03 | -11.02 | Upgrade |
Net Income to Common | 1.89 | 28.35 | -7.08 | 1.03 | -11.02 | Upgrade |
Net Income Growth | -93.34% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Change (YoY) | 2.97% | - | - | - | - | Upgrade |
EPS (Basic) | 0.36 | 5.56 | -1.39 | 0.20 | -2.16 | Upgrade |
EPS (Diluted) | 0.36 | 5.56 | -1.39 | 0.20 | -2.16 | Upgrade |
EPS Growth | -93.53% | - | - | - | - | Upgrade |
Free Cash Flow | -10.82 | -5.74 | 2.07 | -0.04 | -8.4 | Upgrade |
Free Cash Flow Per Share | -2.06 | -1.13 | 0.41 | -0.01 | -1.65 | Upgrade |
Gross Margin | 3.41% | 6.27% | 92.29% | 2.54% | 34.51% | Upgrade |
Operating Margin | -7.85% | -10.89% | -157.99% | -256.43% | -149.43% | Upgrade |
Profit Margin | 1.50% | 41.18% | -214.49% | 33.10% | -298.91% | Upgrade |
Free Cash Flow Margin | -8.59% | -8.33% | 62.73% | -1.16% | -227.93% | Upgrade |
EBITDA | -9.23 | -5.15 | -2.77 | -5.42 | -2.91 | Upgrade |
EBITDA Margin | -7.32% | -7.48% | -83.86% | -174.28% | -78.96% | Upgrade |
D&A For EBITDA | 0.66 | 2.35 | 2.45 | 2.56 | 2.6 | Upgrade |
EBIT | -9.89 | -7.5 | -5.21 | -7.98 | -5.51 | Upgrade |
EBIT Margin | -7.85% | -10.89% | -157.99% | -256.43% | -149.43% | Upgrade |
Revenue as Reported | 139 | 106.12 | 3.32 | 13.46 | 4.04 | Upgrade |
Advertising Expenses | - | 0.05 | 0.05 | 0.08 | 0.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.